Rhumbline Advisers »

Aslan Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Aslan Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $793 1.3k 0.61
2023-12-31 $674 1.3k 0.52
2023-09-30 $2.4k 1.3k 1.85
2023-06-30 $4.7k 1.3k 3.65